Jason Hope is an Arizona entrepreneur based in Tucson, AZ. Hope earned an undergraduate degree in finance from Arizona State University. He went on to get his MBA from the W.P. Carey School of Business at ASU.
An article on the Ask Reporter website makes it clear that Hope’s interests quality him as a bit of a polymath. He is both a businessman and a business advisor. That’s not surprising given his education. Jason Hope is also a consulting futurist. With regard to the near future, Hope is enthusiastic about the Internet of Things (IoT). But Hope is also aware of the privacy and security dangers that await eager and often naive embracers of the rapidly growing tech sector. He is also keenly interested in the SENS anti-aging project.
SENS, or Strategies for Engineered Negligible Senescence, is a project co-founded by research gerontologist Aubrey de Grey. De Grey also serves as the research foundation’s Chief Science Officer. Jason Hope said that SENS is not so much interested in living forever. Instead, he said, it’s more about enabling humans to live substantially longer, healthier lives. Learn more about Jason Hope at gust.com
The word “negligible” in the SENS acronym comes from the observation that certain animals decay, or age, at a negligible rate compared to humans. For example, consider long-lived animals like tortoises and hydras. Many of the diseases we most fear are manifestations of the aging process. Alzheimer’s, Parkinson’s, and many cancers are age-related.
Hope’s contributions to SENS are strictly philanthropical. Jason Hope is a businessman, professional investor, and advisor on future trends, but his passion is supporting SENS. Since his initial pledge of $500,000 in 2010, Hope has gone on to contribute over a million dollars to SENS.
Hope’s most recent contributions to SENS are focused on AGE-breakers. AGE is an acronym for advanced glycation end-products. As humans age, harmful metabolic waste products build up in their skin and muscle tissue. AGE’s contribute to the stiffening of blood vessels and the loss of elasticity (wrinkling) in the skin. Current efforts to create AGE-breakers are focused eliminating an AGE compound called glucosepane from human tissues.